| Company Name: | ICO, Inc. | | Ticker Symbol: | ICOC | | | WWW Address: | www.icopolymers.com | | CEO: | A. John Knapp, Jr. | | No. of Employees: | 910 | | Common Issue Type: | CS | | Business Description: | The Company manufactures specialty resins and concentrates and provides specialized polymer processing services.
|
| | | Industry Information: | CHEMICALS - Synthetics [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 4.21 |  -0.18 | 3.62 | 4.82 | 4.45 | 4.41 | 4.29 | 51567 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 119.9 | 27.6 | 2.32 | 0.55 | 0.00 | 0.0 | 0.0 | 5.14 - 1.03 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 4.34 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 119.9 | mil |
| Latest Shares Outstanding | 27.6 | mil |
| Earnings pS (EPS) | 0.55 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 490,880 | $ |
| Effective Tax Rate | 27.5 | % |
| Float | 25.2 | mil |
| Float as % of Shares Outstanding | 91.2 | % |
| Foreign Sales | 311 | mil |
| Domestic Sales | 136 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 11.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 15.5 | % |
| EBITDA Margin | 4.3 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 1.5 | % |
| Return on Assets (ROA) | -0.4 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -0.5 | % |
| Current Ratio | 2.0 | |
| Leverage Ratio (Assets/Equity) | 1.9 | |
| Interest Cover | 1.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.33 | |
| LT Debt/Total Capital | 17.0 | % |
| Working Capital pS | 2.22 | $ |
| Cash pS | 0.85 | $ |
| Book-Value pS | 3.65 | $ |
| Tangible Book-Value pS | 3.49 | $ |
| Cash Flow pS | 0.24 | $ |
| Free Cash Flow pS | 1.49 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.19 | |
| Price/Tangible Book Ratio | 1.24 | |
| Price/Cash Flow | 18.3 | |
| Price/Free Cash Flow | 2.9 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 9.0 | 108 | 736 | 1,319 |
| 4 Weeks | 4.53 | 3.49 | 3.84 | 13.0 | 106 | 884 | 15,032 |
| 13 Weeks | 5.14 | 3.49 | 4.24 | 2.4 | 95 | 966 | 58,938 |
| 26 Weeks | 5.14 | 2.29 | 2.88 | 50.7 | 125 | 1,085 | 135,683 |
| 52 Weeks | 5.14 | 1.03 | 4.49 | -3.3 | 78 | 1,066 | 265,324 |
| YTD | 5.14 | 1.03 | - | 37.3 | 112 | 1,053 | 239,048 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 4.12 | 4.17 | 4.37 | 3.72 | 3.22 | 2.32 | 2.27 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 9.15 | 59.0 | 3.86 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 16.25 | NA | 39.59 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 11.37 | NA | -31.44 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -35.2 | -39.5 | 6.9 |
| Earnings % | -100.0 | -72.8 | -27.5 |
| EPS % | -100.0 | -70.6 | -27.6 |
| EPS $ | -0.57 | -0.12 | -0.21 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 30.30 |
| Current Ratio | 1.8 |
| Quick Ratio (Acid Test) | 1.0 |
| Liquidity Ratio (Cash) | 0.07 |
| Receivables Turnover | 5.2 |
| Average Collection Period | 69 |
| Working Capital/Equity | 62.1 |
| Working Capital pS | 2.42 |
| Cash-Flow pS | 0.83 |
| Free Cash-Flow pS | -0.04 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.48 |
| Financial Leverage Ratio (Assets/Equity) | 2.1 |
| Debt Ratio | 51.2 |
| Total Debt/Equity (Gearing Ratio) | 0.46 |
| LT Debt/Equity | 0.23 |
| LT Debt/Capital Invested | 24.7 |
| LT Debt/Total Liabilities | 22.2 |
| Interest Cover | 6.2 |
| Interest/Capital Invested | 2.89 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 2.62 |
| Tobin's Q Ratio | 0.54 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 7.14 |
| Enterprise Value (EV)/Free Cash Flow | -518.02 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 1.24 |
| Price/Book Ratio - LTM | 1.19 |
| Price/Cash Flow Ratio | 18.3 |
| Price/Free Cash Flow Ratio - LTM | 2.9 |
| Price/Sales Ratio | 0.37 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 7.4 |
| P/E Ratio (52 weeks ago) - LTM | 5.6 |
| 5-Y High P/E Ratio | 305.0 |
| 5-Y Low P/E Ratio | 5.7 |
| 5-Y Average P/E Ratio | 71.6 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 45.4 |
| PER SHARE FIGURES |
| LT Debt pS | 0.91 |
| Current Liabilities pS | 2.91 |
| Tangible Book Value pS - LTM | 3.49 |
| Book Value pS - LTM | 3.65 |
| Capital Invested pS | 4.81 |
| Cash pS - LTM | 0.85 |
| Cash Flow pS - LTM | 0.24 |
| Free Cash Flow pS - LTM | 1.49 |
| Earnings pS (EPS) | 0.55 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -0.24 |
| Free Cash Flow Margin 5YEAR AVG | 0.44 |
| Net Profit Margin | 3.4 |
| Net Profit Margin - 5YEAR AVRG. | 3.1 |
| Equity Productivity | 4.14 |
| Return on Equity (ROE) | 14.2 |
| Return on Equity (ROE) - 5YEAR AVRG. | 12.1 |
| Capital Invested Productivity | 3.36 |
| Return on Capital Invested (ROCI) | 11.5 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 9.6 |
| Assets Productivity | 1.90 |
| Return on Assets (ROA) | 6.9 |
| Return on Assets (ROA) - 5YEAR AVRG. | 5.4 |
| Gross Profit Margin | 15.5 |
| Gross Profit Margin - 5YEAR AVRG. | 17.9 |
| EBITDA Margin - LTM | 4.3 |
| EBIT Margin - LTM | 0.8 |
| Pre-Tax Profit Margin | 4.7 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 4.3 |
| Effective Tax Rate | 27.5 |
| Effective Tax Rate - 5YEAR AVRG. | 6.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 116 |
| Revenue per Employee | 490,880 |
| Net Income per Employee | 16,829 |
| Average Collection Period | 61 |
| Receivables Turnover | 5.2 |
| Day's Inventory Turnover Ratio | 55 |
| Inventory Turnover | 6.6 |
| Inventory/Sales | 12.0 |
| Accounts Payble/Sales | 8.43 |
| Assets/Revenue | 0.53 |
| Net Working Capital Turnover | 6.67 |
| Fixed Assets Turnover | 6.06 |
| Total Assets Turnover | 1.9 |
| Revenue per $ Cash | 79.93 |
| Revenue per $ Plant | 7.30 |
| Revenue per $ Common Equity | 4.14 |
| Revenue per $ Capital Invested | 3.36 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 9.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 10.6 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |